Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)

BACKGROUND: The quadrivalent human papillomavirus vaccine has been provided in Australia through the National Human Papillomavirus Vaccination Program since April 2007. National registry data demonstrates good coverage of the vaccine, with 73% of school-aged girls having received all three doses. To...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Young, Elisa J, Tabrizi, Sepehr N, Brotherton, Julia ML, Wark, John D, Pyman, Jan, Saville, Marion, Wrede, C David, Jayasinghe, Yasmin, Tan, Jeffrey, Gertig, Dorota M, Pitts, Marian, Garland, Suzanne M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3751671/
https://ncbi.nlm.nih.gov/pubmed/23777549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-296
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak